Have Merck beaten us to the punch?, page-20

Interesting Klotho,

We proved All 47 compounds were tested in the primary screening CPE assay. The criteria for advancement into the secondary YR assay was greater or equal to 30% inhibition of virus

and then we progressed a further Seventeen of the 47 compounds showed sufficient activity fell into this category and progressed to testing in the YR assay. The antiviral activity of 15/17 compounds was confirmed in this assay.

So after this work and good science (12 months work) the Tron BOD decide to synthesis three compounds and send to Scripps. We are all waiting for the magic number to reach over 50% efficacy, surely the Australian Government will promote the Aussie battler Biotech leading the small molecule technology world wide.

It would political bomb for Morrison not to throw full support behind #Biotron if they prove over 50% inhibition of the CoVid virus. Imagine anything over 75% efficacy, your prediction may have some truth to it.

Election round the corner!

Demonstration of reduced virus levels in the lungs of these mice will validate Biotron’s approach and represent a key milestone for the program.

GLTAH's